Keros Therapeutics Inc XNAS: KROS

Mid-range Performer

Download real time

15.76 0.11 (0.70%)

78.22% Fall from 52W High

235.1K

XNAS Volume

XNAS 11 Sep, 2025 5:30 PM (EDT)

Keros Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents